182 related articles for article (PubMed ID: 22152047)
1. Evaluation of immunity against malaria using luciferase-expressing Plasmodium berghei parasites.
Ploemen I; Behet M; Nganou-Makamdop K; van Gemert GJ; Bijker E; Hermsen C; Sauerwein R
Malar J; 2011 Dec; 10():350. PubMed ID: 22152047
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of Plasmodium berghei liver stages by bioluminescence imaging.
Annoura T; Chevalley S; Janse CJ; Franke-Fayard B; Khan SM
Methods Mol Biol; 2013; 923():429-43. PubMed ID: 22990796
[TBL] [Abstract][Full Text] [Related]
3. Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging.
Ploemen IH; Prudêncio M; Douradinha BG; Ramesar J; Fonager J; van Gemert GJ; Luty AJ; Hermsen CC; Sauerwein RW; Baptista FG; Mota MM; Waters AP; Que I; Lowik CW; Khan SM; Janse CJ; Franke-Fayard BM
PLoS One; 2009 Nov; 4(11):e7881. PubMed ID: 19924309
[TBL] [Abstract][Full Text] [Related]
4. Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites.
van der Velden M; Rijpma SR; Verweij V; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Franke-Fayard BM; Russel FG; Janse CJ; Sauerwein RW; Koenderink JB
Am J Trop Med Hyg; 2016 Aug; 95(2):378-82. PubMed ID: 27296385
[TBL] [Abstract][Full Text] [Related]
5. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization.
Nganou-Makamdop K; Ploemen I; Behet M; Van Gemert GJ; Hermsen C; Roestenberg M; Sauerwein RW
Parasite Immunol; 2012 Dec; 34(12):562-9. PubMed ID: 23171040
[TBL] [Abstract][Full Text] [Related]
6. Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii.
Miller JL; Murray S; Vaughan AM; Harupa A; Sack B; Baldwin M; Crispe IN; Kappe SH
PLoS One; 2013; 8(4):e60820. PubMed ID: 23593316
[TBL] [Abstract][Full Text] [Related]
7. Local immune response to injection of Plasmodium sporozoites into the skin.
Mac-Daniel L; Buckwalter MR; Berthet M; Virk Y; Yui K; Albert ML; Gueirard P; Ménard R
J Immunol; 2014 Aug; 193(3):1246-57. PubMed ID: 24981449
[TBL] [Abstract][Full Text] [Related]
8. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM
Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections.
Liehl P; Meireles P; Albuquerque IS; Pinkevych M; Baptista F; Mota MM; Davenport MP; Prudêncio M
Infect Immun; 2015 Mar; 83(3):1172-80. PubMed ID: 25583524
[TBL] [Abstract][Full Text] [Related]
10. 4(1H)-Quinolones with liver stage activity against Plasmodium berghei.
Lacrue AN; Sáenz FE; Cross RM; Udenze KO; Monastyrskyi A; Stein S; Mutka TS; Manetsch R; Kyle DE
Antimicrob Agents Chemother; 2013 Jan; 57(1):417-24. PubMed ID: 23129047
[TBL] [Abstract][Full Text] [Related]
11. Antigen export during liver infection of the malaria parasite augments protective immunity.
Montagna GN; Beigier-Bompadre M; Becker M; Kroczek RA; Kaufmann SH; Matuschewski K
mBio; 2014 Jul; 5(4):e01321-14. PubMed ID: 25073641
[TBL] [Abstract][Full Text] [Related]
12. Parasite load stemming from immunization route determines the duration of liver-stage immunity.
Patel H; Althubaiti N; Parmar R; Yadav N; Joshi U; Tyagi RK; Krzych U; Dalai SK
Parasite Immunol; 2019 Jul; 41(7):e12622. PubMed ID: 30854655
[TBL] [Abstract][Full Text] [Related]
13. Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNγ responses of hepatic CD8+ memory T cells.
Nganou-Makamdop K; van Gemert GJ; Arens T; Hermsen CC; Sauerwein RW
PLoS One; 2012; 7(5):e36508. PubMed ID: 22563506
[TBL] [Abstract][Full Text] [Related]
14. A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.
Jaijyan DK; Singh H; Singh AP
J Biol Chem; 2015 Aug; 290(32):19496-511. PubMed ID: 25960542
[TBL] [Abstract][Full Text] [Related]
15. Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages.
Flores-Garcia Y; Herrera SM; Jhun H; Pérez-Ramos DW; King CR; Locke E; Raghunandan R; Zavala F
Malar J; 2019 Dec; 18(1):426. PubMed ID: 31849326
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
Friesen J; Matuschewski K
Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.
Leitner WW; Bergmann-Leitner ES; Angov E
Malar J; 2010 May; 9():145. PubMed ID: 20507620
[TBL] [Abstract][Full Text] [Related]
18. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.
van Dijk MR; Douradinha B; Franke-Fayard B; Heussler V; van Dooren MW; van Schaijk B; van Gemert GJ; Sauerwein RW; Mota MM; Waters AP; Janse CJ
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12194-9. PubMed ID: 16103357
[TBL] [Abstract][Full Text] [Related]
19. Long-term live imaging reveals cytosolic immune responses of host hepatocytes against Plasmodium infection and parasite escape mechanisms.
Prado M; Eickel N; De Niz M; Heitmann A; Agop-Nersesian C; Wacker R; Schmuckli-Maurer J; Caldelari R; Janse CJ; Khan SM; May J; Meyer CG; Heussler VT
Autophagy; 2015; 11(9):1561-79. PubMed ID: 26208778
[TBL] [Abstract][Full Text] [Related]
20. Antibody-Mediated Protection against
Flores-Garcia Y; Nasir G; Hopp CS; Munoz C; Balaban AE; Zavala F; Sinnis P
mBio; 2018 Nov; 9(6):. PubMed ID: 30459199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
